CompaniesInTheUK

ADAPTATE BIOTHERAPEUTICS LTD

Company number 12166787 ·

Dissolved

Overview

Company type
Private Limited Company
Incorporated
2019-08-21
Dissolved
2025-07-08
Registered office
1 Kingdom Street, London, England, W2 6BD
Postcode
W2 6BD
Capital
5 GBP
Accounts category
Small
Charges
0 outstanding

Accounts

Last made up to
2023-03-31
Financial year end
31 March

Confirmation statement

Last statement dated
2024-08-20
View filing history →

Nature of business (SIC)

  • 72110 Research and experimental development on biotechnology

Officers 4 current · 8 resigned

Bryan DRISCOLL Secretary
Appointed 2022-04-26
Emma Jane, Dr ROFFE Director
Pharmaceuticals General Management Appointed 2022-04-26
MR LOIC VINCENT Director
VP, IMMUNO-ONCOLOGY & CELL THERAPY DISCOVERY Appointed 2019-10-11
MR DANIEL MATTHEW KEMP Director
VP, HEAD OF OPERATIONS AND BD FOR CELL THERAPIES Appointed 2019-10-11

View all officers and resignations →

Group structure

Controlled by ABINGWORTH LLP — since 2019-10-17

From persons-with-significant-control filings on the public register.

Contact details

Website
adaptate.co.uk

Takeda is a patient-focused, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future.

The class of 2019

39%

of the 500 companies in this sector incorporated in 2019 are still active today; 57% have since been dissolved.

A fact about the year, not a forecast for this company.